Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 10—October 2014
Dispatch

Human Granulocytic Anaplasmosis, South Korea, 2013

Kye-Hyung Kim1, Jongyoun Yi1, Won Sup Oh, Nak-Hyun Kim, Su Jin Choi, Pyoeng Gyun Choe, Nam-Joong Kim, Jong-Koo Lee, and Ghazi KayaliComments to Author 
Author affiliations: Seoul National University College of Medicine, Seoul, South Korea (K.-H. Kim, N.-H. Kim, S.J. Choi, P.G. Choe, N.-J. Kim, J.-K. Lee, M.-D. Oh); Pusan National University School of Medicine, Busan, South Korea (J. Yi); Kangwon National University School of Medicine, Chuncheon, South Korea (W.S. Oh)

Main Article

Table

Laboratory findings for patient with human granulocytic anaplasmosis, South Korea, 2013*

Laboratory test (reference range) Day 5† Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 Day 19‡
Leukocytes, cells/μL (3,800–10,000) 2,400 1,100 7,400 5,800 5,200 5,700 4,800 5,700
Neutrophils, % (40–70) 91 28 79 62 50 42 39 51
Lymphocytes, % (20–50) 7 64 17 31 39 45 47 42
Hb, g/dL (12.3–15.3) 9.4 9.3 9.4 8.7 8.8 10.4 9.8 10.3
Hct, % (36.6–44.2) 28.5 27.3 28.8 26.4 27.4 32.5 30.5 31.0
Platelets/μL (140,000–400,000) 78,000 61,000 63,000 69,000 105,000 194,000 249,000 348,000
AST, IU/L (15–41) 137 179 80 48 106 111 64 25
ALT, IU/L (14–54) 60 93 73 55 84 105 83 26
CPK, IU/L (38–234) 74 156 148 64 41 31 NA 39
LDH, IU/L (100–190) 280 384 275 203 243 239 180 134
Creatinine, mg/dL (0.4–1.0) 0.8 0.7 0.5 0.5 0.5 0.7 NA 0.6
C-reactive protein, mg/dL (0–0.50) 6.11 7.04 NA NA NA NA 0.62 NA
PT, INR (0.92–1.17) 1.05 1.17 1.00 0.97 NA NA NA NA
aPTT, s (31.0–43.7) 44.8 57.6 49.3 41.5 NA NA NA NA
Fibrinogen, mg/dL (207–408) NA 304 328 308 NA NA NA NA

*Day 0 was day of illness onset. Hb, hemoglobin; Hct, hematocrit; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CPK, creatine phosphokinase; NA, not available; LDH, lactate dehydrogenase; PT, prothrombin time; INR, international normalized ratio; aPTT, activated partial thromboplastin time.
†Blood samples for culture and for immunofluorescence antibody test were obtained.
‡Blood samples for immunofluorescence antibody test were obtained.

Main Article

1These authors contributed equally to this article.

Page created: September 22, 2014
Page updated: September 22, 2014
Page reviewed: September 22, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external